Free shipping on all orders over $ 500

Sulpiride

Cat. No. M5984

All AbMole products are for research use only, cannot be used for human consumption.

Sulpiride Structure
Synonym:

Dolmatil, Dobren, Sulpyrid, Aiglonyl, Dogmatil

Size Price Availability Quantity
100mg USD 60  USD60 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Sulpiride is a dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid.

Chemical Information
Molecular Weight 341.43
Formula C15H23N3O4S
CAS Number 15676-16-1
Solubility (25°C) 68 mg/mL in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lai EC, et al. PLoS One. Detecting potential adverse reactions of sulpiride in schizophrenic patients by prescription sequence symmetry analysis.

Related Dopamine Receptor Products
AJ-76

AJ-76 ((+)-AJ 76; (1S,2R)-AJ 76) is a dopamine autoreceptor antagonist.

A-412997 

A-412997 is a selective Dopamine D4 agonist with Ki values of 12 and 7.9 nM for the rat and human receptors.

SKF 81297 

SKF 81297 is a potent and selective dopamine D1 receptor agonist.

GBR 12783 

GBR 12783 is a specific, potent and selective dopamine uptake inhibitor that inhibits the [3H]dopamine uptake by rat and mice striatal synaptosomes with IC50s of 1.8 nM and 1.2 nM, respectively.

RMI-61140 

RMI-61140 is an orally active neuroleptics.

  Catalog
Abmole Inhibitor Catalog




Keywords: Sulpiride, Dolmatil, Dobren, Sulpyrid, Aiglonyl, Dogmatil supplier, Dopamine Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.